Advertisement

Topics

Companies Related to "Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer" [Most Relevant Company Matches] RSS

19:55 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Combination Chemotherapy Followed Peripheral Stem Cell Transplantation Treating" Companies 1–25 of 2,100+

Extremely Relevant

America Stem Cell, Inc.

America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of stem cell enabling technologies/products to transform clinical outcomes for patients undergoing stem cell transplantation. The key stem cell enabling platform technologies/compound...


Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. By creating a platform focused on critical areas of transplant medicine, Magenta Therapeutics is pioneering an integrated, but modular approach to stem cell therapies to cre...


Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune ...

Relevant

Medistem Inc

Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell being developed for critical limb ischemia and congestive heart failure. Curr...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies....

ReNeuron

ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

Vitro Diagnostics

We develop stem cell technology for potential use in diabetes research and treatment. Our research has led to a patent-pending method for generation of adult stem cells from cells isolated from tissues. While embryonic stem cells are capable of differentiation into all of the various cells of the body, adult stem cells are more limited in differentiation capacity generally including the cell typ...

National Stem Cell Foundation

The National Stem Cell Foundation (NSCF) is a charitable 501(c)3 organization that funds adult stem cell and regenerative medicine research to accelerate treatment options, advocates for patients participating in clinical trials and supports STEM education to inspire the next generation of researchers and scientists nationwide. For more information, visit ...

HemoGenix, Inc.

HemoGenix® is a privately-held Contract Research Service and Assay Development Laboratory based in Colorado Springs, Colorado. Specializing in predictive in vitro stem cell toxicity testing, HemoGenix provides its services to small, medium and many of the largest biopharmaceutical companies. The proprietary assays developed for its contract services are...

StemCyte, Inc.

StemCyte, Inc. is a leading, global umbilical cord blood ("UCB") stem cell transplantation and therapeutic products company. StemCyte, headquartered in Southern California has UCB storage facilities in both California and in Taiwan which collect, processes and stores UCB stem cells to be used as therapeutic treatments. Stem cells are used to replace or initiate the production of other cells that a...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis AB and Ectycell SAS, possesses broad expertise in pluripotent stem cells, including iPS cell technology, genetic engineering and specialised cells. Cellectis stem cells is developi...

The New York Stem Cell Foundation

The New York Stem Cell Foundation (NYSCF) is an independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF, a global community of over 140 leading stem cell researchers and neuroscientists, employs over 45 researchers at the NYSCF Research Institute, located in New York, and is an ackno...

International Society for Stem Cell Research

The International Society for Stem Cell Research is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell res...

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our stem cell technologies into non-therapeutic areas such as drug discovery - our ReNcell product.We have proprietary stem cell technologies which we believe confer significant advantages over competitor te...

National Stem Cell Holding, Inc.

National Stem Cell Holding, Inc. is a biotechnology company focused on the development and commercialization of cell therapeutics primarily for diabetes and cardiac disease, and cosmetics derived from stem cells. For more information, visit http://www.proteoderm.com, and http://www.proteonomix.com.

Epistem Plc

Epistem is a biotechnology company commercialising its expertise in epithelial stem cells in the areas of oncology, gastrointestinal and dermatological diseases. Epistem develops innovative therapeutics and biomarkers and provides contract research services to drug development companies. The Group's expertise is focused on the regulation of adult stem cells located in epithelial tissue, which ...

Cell Therapy Foundation

The Cell Therapy Foundation is a not-for-profit organization committed to advancing the treatment of disease using adult stem cells. Emerging as a leader in raising funds for adult stem cell research, Cell Therapy Foundation strives to increase awareness about adult stem cells, to fund adult stem cell research addressing several specific diseases, and to accelerate the rate of research and clini...

Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com) is Asia's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell ther...

Stem Cell Sciences plc

Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK and USA have achieved germ-line transmission from embryonic stem (ES) cells in rats using technologies exclusively licensed to the company by Edinburgh University. This is believed to be the first tim...

Medistem Inc.

Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell being developed for critical limb ischemia and congestive heart failure. A pu...

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem cell Research Institute in Korea. R-Japan’s proprietary technology is to isolate, multiply, and store adult mesenchymal stem cells with ensuring genetic integrity. R-Japan currently ...

Beike Biotechnology Co. Ltd.

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell th...

Gamida Cell

Gamida Cell is a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. The company’s pipeline of stem cell therapy products are in development to treat a wide range of conditions including blood cancers such as leukemia and lymphoma, solid tumors, autoimmune diseases, ...

Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. Vet-Stem hol...


More From BioPortfolio on "Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks